Literature DB >> 103466

Thiopental amelioration of brain damage after global ischemia in monkeys.

A L Bleyaert, E M Nemoto, P Safar, S M Stezoski, J J Mickell, J Moossy, G R Rao.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 103466     DOI: 10.1097/00000542-197812000-00003

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  15 in total

Review 1.  Neuroanesthesia: from bench to bed.

Authors:  Mishiya Matsumoto; Kazuyoshi Ishida
Journal:  J Anesth       Date:  2012-02-29       Impact factor: 2.078

Review 2.  Barbiturates in severe head injuries?

Authors:  D Moskopp; F Ries; H Wassmann; J Nadstawek
Journal:  Neurosurg Rev       Date:  1991       Impact factor: 3.042

3.  Anesthesiology-epitomes of progress: barbiturates and cerebral ischemia.

Authors:  M M Todd
Journal:  West J Med       Date:  1981-11

Review 4.  The clinical use of barbiturates in neurological disorders.

Authors:  M C Smith; B J Riskin
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

5.  The neurologic sequelae of cardiac arrest.

Authors:  W T Longstreth
Journal:  West J Med       Date:  1987-08

6.  Barbiturates and brain ischemia, again.

Authors:  N S Abramson
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

7.  Prevention and treatment of brain ischaemia.

Authors:  C J Hinds
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-21

8.  Recovery of consciousness after an 18-min global cerebral ischemia.

Authors:  Tatsuhiko Kano; Keiji Gotoh; Kohichi Ashimura; Hiraaki Gotoh; Kazufumi Okamoto
Journal:  J Anesth       Date:  1994-12       Impact factor: 2.078

9.  Status epilepticus treated by barbiturate anaesthesia.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-04-04

10.  The neurologic effects of thiopental therapy after cardiac arrest.

Authors:  F Monsalve; L Rucabado; M Ruano; J Cuñat; V Lacueva; A Viñuales
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.